期刊文献+

高血压合并糖尿病患者的降压治疗 被引量:5

下载PDF
导出
摘要 高血压与糖尿病均为最常见的心血管危险因素,且常同时并存。两者合并存在使心血管疾病的死亡率增加2~8倍,糠尿病人群中高血压的患病率是普通人的1.5~3倍。我国在高血压人群中,糖尿病的患病率是正常血压人群的2.5倍。英国前瞻性糖尿病研究(UKPDS)发现,对于糖尿病合并高血压患者,严格控制血压可使任何糖尿病相关终点事件的发生率下降24%,微血管病变下降37%,心肌梗死下降44%;而强化控制血糖仅使任何糖尿病相关终点下降12%,微血管病变下降25%,心肌梗死下降16%。因此,严格控制血压比强化血糖更为重要。
出处 《中国医药导刊》 2009年第7期1087-1088,共2页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献10

  • 1徐焱成.糖尿病患者合并高血压对降压药物的选择和应用[J].中国糖尿病杂志,2006,14(6):405-407. 被引量:57
  • 2路影,杨华章.糖尿病合并高血压治疗进展[J].国外医学(内分泌学分册),2004,24(6):391-394. 被引量:33
  • 3Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure[J].JAMA,2003;2899(19):2560-2572.
  • 4Mogensen CE,Neldarn S,Tikkanen l,et al.Randomised controled trial of dual bloc logic of rerun angiotensin system in patients with hypertension,microalbum inuria,and noninsulin dependent diabetes:the candsatran and lisinopril ricroalbu minutia(CALM)study[J].BMJ,2000;321:1440-1444.
  • 5Brenner BM,Coopr ME,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J].N Engl J Med,2001;345:861-869.
  • 6Pahor M.Therapeutic benefits of ACE inhibitor and other antihypertensive drugs in patients with type 2 diabetes[J].Diabtos Care,2000;23:888-892.
  • 7Lewis FJ,Hunsieker LG,Clarke WR,et al.Renoprotective efect of the angiotensin-receptor antagonist irbesartan in patients whit nephropathy due to type 2 diabetes[J].New Engl J Med,2001;345:851-860.
  • 8Baba S,The J-Mind Study Group.Nifedipine and enalapril equaly reduce the progression of nephropathy in hypertensive type 2 diabetes[J].Diabetes Res Clin Pract,2001;54:191-201.
  • 9ALLHAT CoUaborative Research Group.Major outcomes in high-risk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial(AId,HAT)[J].JAMA,2007;288:2981-2997.
  • 10杜秀娟,张保功.糖尿病高血压降压药物的合理选择[J].滨州医学院学报,2003,26(3):204-205. 被引量:12

二级参考文献34

  • 1Uehara MH, Kohlmann NE,Zanella MT,et al. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab, 2001,3: 319-325.
  • 2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA, 2003,289: 2560-2572.
  • 3The STOP-NIDDM Trial. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA, 2003,290: 486-494.
  • 4Pahor M. Therapeutic benefits of ACE inhibitor and other antihypertensive drugs in patients with type 2 diabetes. Diabtes Care,2000,23:888-892.
  • 5Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New Engl J Med,2001,345:851-860.
  • 6Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001,345: 861-869.
  • 7Tuomilehto J, Rastenyte D, Birkenhagar WH, et al. For the Systolic Hypertension in Europe Trial investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med, 1999,340:677-684.
  • 8ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
  • 9St John SM, Marc R, Paresh D, et al. A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care, 2002, 25: 2058-2064.
  • 10Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000,342:145-153.

共引文献93

同被引文献15

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部